# HCA Healthcare (HCA) Financial Model Free Excel 3-statement financial model and company analysis for HCA Healthcare. - Canonical: https://finamodel.com/companies/hca-healthcare - Industry: Healthcare Services - Downloadable model: Yes - Excel download: https://finamodel.com/company-models/HCA.xlsx ## Model Purpose This model projects the three-statement financials and operating metrics of HCA Healthcare to determine its equity valuation and assess its credit profile, enabling an analyst to evaluate the sustainability of its volume-driven growth and margin expansion in the face of changing payer mixes and wage inflation. ## Company Overview HCA Healthcare is the largest for-profit operator of health care facilities in the United States, managing 190 hospitals and approximately 2,400 ambulatory sites of care. The company generates revenue primarily through inpatient and outpatient services, compensated by Medicare, Medicaid, managed care plans, and commercial insurers. HCA operates a highly capital-intensive, asset-heavy business model that relies on local market density and scale to drive operational efficiencies and negotiate favourable reimbursement rates. Its competitive position is dominant in its core markets (such as Texas and Florida), where it often holds the number one or two market share position. Recent major events include navigating the impacts of Hurricanes Helene and Milton in late 2024 and early 2025, alongside significant benefits from state Medicaid supplemental payment programmes. ## Revenue Deep Dive HCA does not report traditional product segments; instead, it reports consolidated revenue driven by patient volumes and acuity. The model should forecast revenue using the company's primary operating metrics: ### Inpatient Revenues - **Segment name**: Inpatient Revenues - **Revenue driver formula**: Admissions x Revenue per Admission - **Historical growth rate**: 2-4% volume growth, 3-5% pricing/acuity growth. - **Key growth levers and headwinds**: Driven by population growth in core Sunbelt markets, ageing demographics, and physician recruitment. Headwinds include shifts to outpatient care and managed care pushback. - **Pricing dynamics**: Contractual (commercial insurers), regulated (Medicare/Medicaid), and spot (uninsured). - **Revenue recognition notes**: Recognised over time as services are provided, net of contractual adjustments and charity care. - **Seasonality**: Q1 and Q4 are typically stronger due to the respiratory season and patients meeting annual deductibles. ### Outpatient Revenues - **Segment name**: Outpatient Revenues - **Revenue driver formula**: Outpatient Surgeries & ER Visits x Revenue per Visit (often aggregated holistically via Equivalent Admissions) - **Historical growth rate**: 1-3% volume growth. - **Key growth levers and headwinds**: Shift of high-acuity procedures (like orthopaedics and cardiology) to ambulatory surgery centres (ASCs). - **Pricing dynamics**: Lower absolute price per visit than inpatient, but often higher margin. - **Revenue recognition notes**: Recognised at the point of service. - **Seasonality**: Similar to inpatient, with Q4 strength. *Note: For consolidated modelling, HCA analysts project total revenue using "Equivalent Admissions" (which mathematically combines inpatient and outpatient volumes) multiplied by "Revenue per Equivalent Admission".* ## Cost Structure ### Variable Costs / COGS HCA does not report a traditional "Gross Margin" or COGS line. Operating expenses are broken down by nature: - **Salaries and Benefits**: The largest expense, typically 43-45% of revenue. Includes nursing staff, physicians, and contract labour. Highly sensitive to nursing shortages and wage inflation. - **Supplies**: Typically 15-16% of revenue. Includes pharmaceuticals, medical devices, and surgical implants. Scales linearly with equivalent admissions and case mix index (acuity). - **Other Operating Expenses**: Typically 18-20% of revenue. Includes contract services, professional fees, repairs, and maintenance. ### Operating Expenses - **Depreciation & Amortisation**: Typically 4-5% of revenue, reflecting the asset-heavy nature of hospital buildings and expensive medical equipment. - **R&D**: Not applicable / not reported. - **SG&A**: Embedded within "Other Operating Expenses" and corporate allocations. - **Stock-Based Compensation**: Relatively small as a percentage of revenue, typically buried in salaries and benefits. - **Restructuring / one-time charges**: Occasional gains/losses on sales of facilities (e.g., $195 million loss in Q4 2024 for a California hospital sale). ### Margin Profile - **EBITDA Margin**: 20.0% to 21.0% (Adjusted EBITDA was $15.566 billion on $75.600 billion revenue in 2025, yielding 20.6%). - **Operating Margin**: 15.0% to 16.5%. - **Net Margin**: 8.0% to 9.0% (Net income was $6.784 billion in 2025, yielding 9.0%). - **Margin trend**: Expanding slightly due to strong commercial payer mix, state supplemental payments, and cost leveraging, offsetting wage inflation. ## Balance Sheet Structure - **Total assets**: Approximately $60.7 billion as of year-end 2025. - **Key asset categories**: Property and Equipment (PP&E) is the largest component, representing hospitals and equipment. - **Goodwill & intangibles**: Significant due to historical leveraged buyouts and continuous bolt-on hospital acquisitions. - **Working capital profile**: - **Days Sales Outstanding (DSO)**: 45-55 days (receivables from Medicare, Medicaid, and commercial payers). - **Days Inventory Outstanding (DIO)**: 15-20 days (medical supplies and pharmaceuticals). - **Days Payable Outstanding (DPO)**: 50-60 days. - **Net working capital**: Typically negative or slightly positive. The company uses its scale to delay payables while collecting receivables efficiently. - **PP&E**: Consists of land, buildings, and equipment. Useful lives range from 10 to 40 years for buildings and 3 to 10 years for equipment. - **Right-of-use assets**: Material, representing operating leases for medical office buildings and ambulatory centres. ## Capital Expenditure & Investment - **Capex as % of revenue**: 6.0% to 7.0% (Actual 2025 capex was approximately $5.0 billion on $75.6 billion revenue). - **Maintenance capex vs. growth capex**: Roughly 40% maintenance (IT, equipment replacement) and 60% growth (new bed capacity, new ASCs, freestanding ERs). - **Major capex programmes**: Multi-year resiliency initiatives, new electronic medical record platform rollouts, and artificial intelligence investments. - **M&A pattern**: Serial bolt-on acquirer of local hospitals and outpatient facilities to build market density. - **Typical acquisition multiple paid**: 8x to 10x EBITDA before synergies. ## Debt & Capital Structure - **Total debt**: $46.492 billion as of December 31, 2025. - **Net debt**: Approximately $45.452 billion (Total debt less $1.040 billion cash). - **Debt/EBITDA ratio**: Current leverage is approximately 2.9x ($45.45B / $15.56B). Target is typically 3.0x to 4.0x. - **Credit rating**: Investment grade (typically BBB- / Baa3). - **Key debt instruments**: Senior secured term loans, senior unsecured notes, and a large revolving credit facility. - **Interest rate profile**: Predominantly fixed-rate bonds, with some floating exposure via term loans. - **Share repurchase programme**: Highly active. Repurchased $2.558 billion in Q4 2025 alone. Board authorised an additional $10 billion programme in late 2025. - **Dividend policy**: Quarterly dividend of $0.72 per share ($2.88 annualised), representing a yield of roughly 0.6% and a payout ratio of around 10%. ## Cash Flow Characteristics - **Operating cash flow conversion**: Very strong. OCF was $12.6 billion in 2025 compared to net income of $6.78 billion (approx 1.8x conversion). - **Free cash flow margin**: 9.0% to 11.0% (OCF of $12.6B less Capex of $5.0B = $7.6B FCF on $75.6B revenue). - **Major non-cash items**: Depreciation and amortisation ($3.4B+ annually), deferred income taxes, and stock-based compensation. - **Working capital cash flow impact**: Generally a slight use of cash as the business grows, but highly efficient. - **Capex intensity**: High absolute dollars ($5.0B+) but manageable relative to massive operating cash flow. - **Cash tax rate**: Often lower than the GAAP effective rate due to accelerated depreciation on medical equipment and facilities. ## Sheet Structure 1. **Assumptions**: Hardcoded drivers for volume (admissions), pricing (revenue per equivalent admission), cost ratios, capex, and capital returns. 2. **Operating Model**: Projects Equivalent Admissions, Revenue per Equivalent Admission, and calculates total Revenues. 3. **Income Statement**: Consolidated P&L from Revenues down to Net Income Attributable to HCA Healthcare, Inc. 4. **Operating Expenses Schedule**: Detailed build of Salaries and Benefits, Supplies, Other Operating Expenses, and D&A. 5. **Balance Sheet**: Assets, Liabilities, and Stockholders' Deficit (HCA operates with a negative equity balance due to massive historical buyouts and ongoing share repurchases). 6. **Cash Flow Statement**: OCF, CFI, and CFF, linking net income to the ending cash balance. 7. **Debt Schedule**: Tranche-by-tranche debt build, interest expense calculation, and mandatory repayments. 8. **PP&E and Capex Schedule**: Roll-forward of gross PP&E, accumulated depreciation, and capex. 9. **Working Capital Schedule**: Receivables, inventory, and payables driven by days outstanding assumptions. 10. **DCF Valuation**: Unlevered free cash flow build, WACC calculation, and terminal value. ## Key Financial Relationships 1. Total Revenues = Equivalent Admissions x Revenue per Equivalent Admission 2. Equivalent Admissions = Inpatient Admissions x (Total Gross Revenues / Gross Inpatient Revenues) 3. Salaries and Benefits = Total Revenues x Salaries and Benefits Margin (historically 43-45%) 4. Supplies Expense = Total Revenues x Supplies Margin (historically 15-16%) 5. Other Operating Expenses = Total Revenues x Other Operating Margin (historically 18-20%) 6. Adjusted EBITDA = Total Revenues - Salaries and Benefits - Supplies - Other Operating Expenses 7. Depreciation Expense = Beginning Net PP&E x Depreciation Rate 8. Interest Expense = Average Total Debt x Weighted Average Interest Rate 9. Accounts Receivable = (Total Revenues / 365) x DSO 10. Accounts Payable = (Other Operating Expenses + Supplies / 365) x DPO 11. Free Cash Flow = Cash Flow from Operations - Capital Expenditures 12. Shares Outstanding = Prior Period Shares - (Share Repurchases / Average Share Price) ## Cross-Sheet Dependencies - The **Assumptions** sheet feeds the **Operating Model** and **Operating Expenses Schedule**. - The **Operating Model** generates Total Revenues, which feeds the top line of the **Income Statement** and drives the **Working Capital Schedule**. - The **Operating Expenses Schedule** feeds the operating costs on the **Income Statement** and the payables in the **Working Capital Schedule**. - The **Debt Schedule** calculates interest expense, which flows to the **Income Statement**, creating a circular reference if interest expense reduces net income, which reduces cash, which increases revolver borrowing, which increases interest expense. - The **Cash Flow Statement** pulls Net Income from the **Income Statement**, D&A from the **PP&E Schedule**, and working capital changes from the **Working Capital Schedule**. - The ending cash balance from the **Cash Flow Statement** and ending debt from the **Debt Schedule** flow to the **Balance Sheet**. ## Sign Convention - Revenues and operating metrics are positive. - Expenses on the Income Statement (Salaries, Supplies, D&A, Interest) are positive numbers subtracted in subtotals. - Assets are positive; Liabilities and Equity are positive (note that HCA's Retained Earnings/Total Equity is naturally negative, so it should be displayed as a negative number). - Cash Flow Statement: Inflows are positive, outflows (Capex, dividends, share repurchases, debt paydowns) are negative. ## Things Most Likely to Go Wrong - **Medicaid Supplemental Payments**: HCA receives hundreds of millions in state supplemental payments (e.g., from Texas, Florida, Tennessee). These can swing EBITDA significantly and must be modelled as a discrete benefit to revenue and margin. - **Negative Equity**: HCA operates with a massive retained deficit and negative stockholders' equity due to aggressive share buybacks and historical LBOs. The builder must not force equity to be positive; the balance sheet balances with negative equity. - **Equivalent Admissions Math**: The calculation of equivalent admissions is specific to hospital accounting. It scales inpatient admissions by the ratio of total revenue to inpatient revenue. The model must use the consolidated Equivalent Admissions metric to drive total revenue accurately. - **Hurricane Impacts**: Historical data for Q4 2024 and Q1 2025 includes significant disruptions from Hurricanes Helene and Milton. The model should normalise these periods when calculating historical growth rates. - **Non-Controlling Interests**: HCA has significant joint ventures. Net Income must be clearly split between "Net Income" and "Net Income Attributable to HCA Healthcare, Inc." to calculate EPS correctly. - **Share Count Reduction**: HCA retires shares aggressively (over $2.5 billion in Q4 2025 alone). Failing to model the declining share count will severely understate future EPS. - **Gains/Losses on Facility Sales**: These are frequent and distort operating margins. They must be excluded from Adjusted EBITDA. - **Wage Inflation**: Salaries and benefits are highly sensitive to contract labour usage. A 100 bps error in the salaries margin assumption will swing EBITDA by over $750 million. ## Validation Checks - "Adjusted EBITDA margin should be in the 20.0-21.0% range; flag if outside this band." - "Capex as a % of revenue should be between 6.0% and 7.0% based on management guidance." - "Debt/EBITDA should remain between 2.5x and 3.5x; flag if leverage exceeds 4.0x." - "Operating Cash Flow to Net Income conversion should be >1.5x (HCA has exceptionally strong cash conversion)." - "Total Assets = Total Liabilities + Stockholders' Deficit in every period." - "Salaries and Benefits must remain the largest expense line, strictly between 43.0% and 46.0% of revenue." - "Share count must decrease year-over-year given the active $10 billion repurchase authorisation." ## Key Assumptions (Default Values) | Assumption | Default Value | Unit | Rationale | |---|---|---|---| | Equivalent Admissions Growth | 2.4 | % | Actual YoY growth achieved in 2025. | | Revenue per Equivalent Admission Growth | 4.1 | % | Actual YoY growth achieved in 2025, driven by acuity and payer mix. | | Salaries and Benefits Margin | 43.7 | % | Based on H1 2025 actuals ($16.1B on $36.9B revenue). | | Supplies Margin | 15.5 | % | Based on historical averages and 2025 run-rate. | | Other Operating Expenses Margin | 20.7 | % | Based on historical averages and 2025 run-rate. | | Depreciation & Amortisation Margin | 4.6 | % | Based on H1 2025 actuals ($1.72B on $36.9B revenue). | | Capex as % of Revenue | 6.6 | % | Based on $5.0B guidance on ~$75.6B revenue. | | Effective Tax Rate | 23.5 | % | Standard corporate rate plus state taxes, adjusted for historical actuals. | | Annual Share Repurchases | 4,000 | $ Millions | Conservative estimate based on $10B authorisation and recent $2.5B Q4 run-rate. | | Dividend per Share (Annual) | 2.88 | $ | Based on $0.72 quarterly dividend declared in early 2025. | | Average Interest Rate on Debt | 5.5 | % | Blended rate on $46.5B debt portfolio. | | DSO (Days Sales Outstanding) | 50 | Days | Standard hospital revenue cycle collection period. | | DPO (Days Payable Outstanding) | 55 | Days | Standard vendor payment terms. | | WACC | 7.5 | % | Reflects investment-grade debt cost and standard equity risk premium. | | Terminal Growth Rate | 2.0 | % | Long-term inflation and population growth proxy. | ## Data Sources & Benchmarks - **Filings**: SEC EDGAR for HCA Healthcare, Inc. (10-K, 10-Q, 8-K). - **Investor Relations**: investor.hcahealthcare.com for quarterly earnings supplements and guidance presentations. - **Key Peers**: Tenet Healthcare (THC), Universal Health Services (UHS), Community Health Systems (CYH). - **Industry Data**: Centers for Medicare & Medicaid Services (CMS) for rate updates, American Hospital Association (AHA) for admission trends. - **Proprietary Data**: Definitive Healthcare or Trilliant Health for local market share and physician referral patterns. ## Sources - HCA Healthcare Q4 2025 Earnings Release and Financial Supplement - HCA Healthcare 2025 Form 10-K - Paul Keckley: Is HCA the Exception or the Rule? (February 2026) - Fierce Healthcare: HCA Healthcare raises 2025 guidance (October 2025) - Hospitalogy: HCA Q1 25 Breakdown (April 2025) --- ## Frequently asked questions ### What is HCA Healthcare's primary business model? HCA Healthcare operates as the largest for-profit provider of healthcare facilities in the United States, managing 190 hospitals and approximately 2,400 ambulatory sites. The company generates revenue through inpatient and outpatient services, compensated by various payers including Medicare, Medicaid, and commercial insurers. ### How does HCA Healthcare generate its revenue? HCA Healthcare's consolidated revenue is primarily driven by patient volumes and the acuity of services provided across its facilities. The company leverages its local market density and scale to achieve operational efficiencies and negotiate favorable reimbursement rates with payers. ### What are the key capital expenditure assumptions for HCA Healthcare's financial model? The financial model assumes HCA Healthcare's capital expenditure as a percentage of revenue is approximately 6.86%, aligning with its asset-heavy business model. Roughly 60% of this capex is allocated to growth initiatives such as new bed capacity and ambulatory centers, with the remainder for maintenance. ### What is the assumed revenue growth rate for HCA Healthcare in financial projections? In the financial model, HCA Healthcare's revenue growth is assumed to be approximately 6.06%. This projection considers the company's ability to sustain volume-driven growth and manage margin expansion amidst factors like changing payer mixes and wage inflation. ### What are important considerations for valuing HCA Healthcare using a Discounted Cash Flow (DCF) model? Key considerations for a DCF model include assessing the sustainability of HCA Healthcare's volume-driven growth and margin expansion, given its capital-intensive operations. Analysts must also account for its significant goodwill and intangibles, which stem from historical leveraged buyouts and continuous bolt-on acquisitions. ### Can I download an Excel financial model for HCA Healthcare? Yes, an Excel financial model for HCA Healthcare is available for download, providing projections for the fiscal years 2026 through 2030. This model allows analysts to evaluate the company's equity valuation and assess its credit profile. [Interactive forecast calculator](https://finamodel.com/companies/hca-healthcare/forecast)